Ryan Specialty (NYSE:RYAN) Cut to “Strong Sell” at Zacks Research

Ryan Specialty (NYSE:RYAN) was downgraded by stock analysts at Zacks Research from a “hold” rating to a “strong sell” rating in a report issued on Tuesday,Zacks.com reports.

A number of other brokerages also recently weighed in on RYAN. JPMorgan Chase & Co. cut their price target on shares of Ryan Specialty from $63.00 to $56.00 and set an “underweight” rating on the stock in a research report on Wednesday, January 7th. Wells Fargo & Company lowered their target price on shares of Ryan Specialty from $63.00 to $56.00 and set an “overweight” rating for the company in a research note on Friday, February 13th. Barclays reduced their price target on shares of Ryan Specialty from $58.00 to $52.00 and set an “overweight” rating on the stock in a research report on Friday, February 13th. Weiss Ratings cut shares of Ryan Specialty from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Thursday, February 5th. Finally, Piper Sandler dropped their price objective on Ryan Specialty from $58.00 to $43.00 and set a “neutral” rating on the stock in a research note on Friday, February 13th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, five have assigned a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat, Ryan Specialty presently has an average rating of “Hold” and an average target price of $57.47.

Ryan Specialty Stock Down 2.2%

Shares of Ryan Specialty stock opened at $38.01 on Tuesday. The business has a fifty day simple moving average of $47.95 and a 200 day simple moving average of $52.90. The stock has a market cap of $10.04 billion, a PE ratio of 90.50, a price-to-earnings-growth ratio of 1.02 and a beta of 0.62. The company has a quick ratio of 0.98, a current ratio of 0.98 and a debt-to-equity ratio of 2.62. Ryan Specialty has a 12 month low of $37.29 and a 12 month high of $77.16.

Ryan Specialty (NYSE:RYAN) last released its earnings results on Thursday, February 12th. The company reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.50 by ($0.05). The company had revenue of $751.21 million during the quarter, compared to analyst estimates of $777.43 million. Ryan Specialty had a net margin of 7.02% and a return on equity of 46.41%. The company’s quarterly revenue was up 13.2% compared to the same quarter last year. During the same period in the previous year, the company posted $0.45 EPS. Research analysts predict that Ryan Specialty will post 2.29 EPS for the current year.

Insider Buying and Selling at Ryan Specialty

In related news, Director Patrick G. Ryan, Jr. acquired 25,500 shares of the business’s stock in a transaction that occurred on Monday, February 23rd. The shares were acquired at an average cost of $39.96 per share, with a total value of $1,018,980.00. Following the transaction, the director owned 428,295 shares of the company’s stock, valued at $17,114,668.20. The trade was a 6.33% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Timothy William Turner sold 129,570 shares of the company’s stock in a transaction on Friday, December 12th. The stock was sold at an average price of $53.61, for a total transaction of $6,946,247.70. Following the completion of the transaction, the chief executive officer directly owned 12,553 shares of the company’s stock, valued at approximately $672,966.33. The trade was a 91.17% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 52.21% of the company’s stock.

Institutional Investors Weigh In On Ryan Specialty

A number of hedge funds and other institutional investors have recently bought and sold shares of RYAN. Vulcan Value Partners LLC grew its stake in shares of Ryan Specialty by 631.7% in the fourth quarter. Vulcan Value Partners LLC now owns 4,621,079 shares of the company’s stock valued at $238,536,000 after buying an additional 3,989,502 shares in the last quarter. T. Rowe Price Investment Management Inc. raised its position in Ryan Specialty by 79.9% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 7,552,002 shares of the company’s stock worth $389,910,000 after acquiring an additional 3,353,926 shares in the last quarter. Independent Franchise Partners LLP acquired a new stake in Ryan Specialty in the third quarter valued at $95,798,000. Adage Capital Partners GP L.L.C. grew its position in shares of Ryan Specialty by 1,510.0% in the 4th quarter. Adage Capital Partners GP L.L.C. now owns 1,610,000 shares of the company’s stock valued at $83,124,000 after acquiring an additional 1,510,000 shares during the period. Finally, Champlain Investment Partners LLC increased its stake in shares of Ryan Specialty by 76.9% during the 3rd quarter. Champlain Investment Partners LLC now owns 3,066,011 shares of the company’s stock worth $172,800,000 after purchasing an additional 1,332,773 shares during the last quarter. Institutional investors and hedge funds own 84.82% of the company’s stock.

About Ryan Specialty

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.